A Phase 2, monocentric, prospective, nonrandomized, open-label, experimental study to evaluate efficacy and safety of intrabronchial instillation of liposomal Amphotericin B in patients with simple pulmonary aspergilloma. - BRO-LAMB
Latest Information Update: 25 Mar 2026
At a glance
- Drugs Amphotericin B liposomal (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- Acronyms BRO-LAMB
Most Recent Events
- 25 Mar 2026 New trial record